Pharmaceutical Technology, May 2, 2009 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharmaceutical Technology, May 2, 2009
Online Exclusive
Taiwan Seeks to Strengthen its Intellectual Property Governance
By Patricia Van Arnum
Taiwan sees to bring its intellectual property laws and enforcment into better alignment with international standards.
Special Report
Easing the Bottleneck
By Michelle Hoffman
Manufacturers of therapeutic monoclonal antibodies consider new paradigms in purification technologies.
Taiwan, No Longer a Life-Sciences Island Unto Itself
By Patricia Van Arnum
Taking a cue from its electronics industry, Taiwan is seeking to put its biotechnology and pharmaceutical industries on the map. An interactive map shows pharmaceutical activity in Taiwan.
Peer-Reviewed Research
Initial Solvent Screening of Carbamazepine, Cimetidine, and Phenylbutazone: Part 1 of 2
By Tu Lee , Yan Chan Su , Hung Ju Hou , Hsiang Yu Hsieh
The authors describe the importance of a rapid and an abbreviated screening strategy by initial solvent screening in 20-mL scintillation vials.
Ethyl Lactate as a Pharmaceutical-Grade Excipient and Development of a Sensitive Peroxide Assay
By Jason T. McConville , Thiago C. Carvalho , Shawn A. Kucera , Elizabeth Garza
The authors investigate whether the addition of an antioxidant could be used to stabilize the solvent ethyl lactate by preventing the formation of peroxides
Ingredients Insider
Assessing Market Opportunities in Contract Biologics Manufacturing
By Patricia Van Arnum
Strong growth in biopharmaceuticals bodes well for contract manufacturing, but the perils and the promises of pipelines remain.
Outsourcing Outlook
Limits to Growth?
By Jim Miller
A major CRO ventures further into proprietary drug development.
Washington Report
The Comparative-Effectiveness Controversy
By Jill Wechsler
Government funding is slated to boost comparative studies of prescription drugs.
Packaging Forum
To Protect and Package
By Hallie Forcinio
Products at INTERPHEX focused on protection, compliance, and deterring counterfeiting. This article contains bonus online-exclusive material.
Guest Editorial
Biotechnology in 2009
By James C. Greenwood
The president of BIO proposes the ingredients needed for industry growth.
Viewpoint
Industry Leaders Debate Follow-on Biologics Pathway
By James C. Greenwood , Kathleen Jaeger
The organizations' presidents discuss market exclusivity, approval processes, and pending legislation.
Inside IPEC
Inside IPEC: Good Distribution Practices for Pharmaceutical Excipients
By Mathias Brenken , Andreas Lekebusch , Wilhelm Gierling , Steve Hewitt , Allan Whiston , Frank Milek
The GDP committee of IPEC–Europe is trying to seal one more broken link in the supply chain. This article contains bonus online-exclusive material.
PharmTech Talk
Shop Floor and Top Floor, Unite!
By Erik Greb
Technology can solve enterprise-level problems.
Agent-In-Place
Missing Something?
By Control, a senior compliance officer
Process steps, GMP documents, a purification vessel, and validation seem to disappear.
In the Spotlight
In the Spotlight
Editors' Picks of Pharmaceutical Science & Technology Innovations
News
Report From: Japan
By Jane Wan
The Japanese government is eager to jumpstart its generic-drug market, but changes must come first.
Pharma Capsules
Pharma Capsules
Brief pharmaceutical news items for May 2009.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
29%
Oversee medical treatment of patients in the US.
10%
Provide treatment for patients globally.
6%
All of the above.
42%
No government involvement in patient treatment or drug development.
13%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Click here